Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • ID: 3905388
  • Report
  • Region: Global
  • 173 Pages
  • BCC Research
1 of 6
The Global Market for Gastrointestinal Disorder Therapeutics and Diagnostics is Expected to Grow from Nearly $51.8 Billion in 2016 to $63.8 Billion in 2021 at a CAGR of 4.3%

FEATURED COMPANIES

  • Allergan Plc
  • Astrazeneca
  • ELI Lilly And Company
  • Immunogenx
  • New Link Genetics
  • Roche
  • MORE

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

This report provides:

  • An overview of the global markets for gastrointestinal therapeutics and diagnostics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
  • Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.

This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

As already mentioned, the market for gastrointestinal pharmaceuticals is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals.

Similarly, the market for gastrointestinal diagnostics, testing and vaccines is divided into three general segments:

  • Diagnostics and testing market.
  • Medical devices (endoscopy)
  • Vaccines.

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following:

  • Gastrointestinal tract disorders.
  • Gastrointestinal tract walls disorders.
  • Gastrointestinal motility disorders.
  • Gastrointestinal cancers.

Each sub-segment is covered in detail, describing the disorders and diseases, identifying currently available and potential products, and competitors.

Intended Audience

The information and analyses presented in this report are important decision-making tools for managers involved in business development, marketing, market research, product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, and for consultants to the pharmaceutical and biotechnology industry. The study provides a comprehensive analysis of the current and five-year estimated markets for gastrointestinal drugs and, in particular, the market potential of technologies under development in the gastrointestinal diagnostic arena.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Allergan Plc
  • Astrazeneca
  • ELI Lilly And Company
  • Immunogenx
  • New Link Genetics
  • Roche
  • MORE

1: Introduction Complimentary

  • Study Goals And Objectives
  • Reasons For Doing The Study
  • Intended Audience
  • Scope Of Report
  • Methodology And Information Sources

2: Executive Summary

  • Gastrointestinal Therapeutics And Diagnostics

3: Overview

  • Gastric Cancer
  • Inflammatory Bowel Disease (IBD)
  • Constipation
  • Opioid-Induced Constipation
  • Gastroesophageal Reflux Disease
  • Table 1 : U.S. Incidence Of Individual Pathogens
  • Table 2 : Estimated Incidence/Prevalence/Mortality Of Selected Gi Conditions In The U.S.

4: Etiology

  • Anatomy And Physiology Of The Gastrointestinal System
  • The Enteric Nervous System: An Overview
  • Factors Affecting The Functioning Of The GI System
  • Physiology Of The Gi System And The Role Of Each Part In The Gi Process

5: Prescription Therapy Market

  • Antidiarrheals
  • Antiemetics
  • Gastrointestinal Cancer Treatments
  • Gastroesophageal Reflux Disease Treatments
  • Proton Pump Inhibitors
  • Laxatives
  • Bowel Anti-Inflammatory
  • Other GI Drugs
  • Table 11 : Global Market For Prescription Gi Therapies, By Category, Through 2021

6: OTC Therapy Market

  • Antacids
  • Locally Acting Antidiarrheals
  • H2 Inhibitors
  • Proton Pump Inhibitors
  • Laxatives
  • Total OTC Gastrointestinal Drug Market Size And Growth

7: Diagnostics And Devices Market

  • Enteric Disease Testing Methods
  • Global Market For Enteric Diagnostic Tests
  • Campylobacter
  • Norovirus
  • Rotavirus
  • Giardia Parasite
  • E. Coli
  • Cryptosporidium
  • Shigella
  • Typhoid
  • Amebiasis
  • Cholera
  • Other (H. Pylori, Yersinia) Diagnostic Tests
  • Medical Devices (Endoscopy)

8: Gastrointestinal Product Pipeline

  • Therapies For Treating Gastric Cancer
  • Gerd And Peptic Ulcers
  • Therapies For Treating IBS
  • Therapies For Treating Ulcerative Colitis And Crohn’S Disease

9: Patents

  • Table 71 : Patents Issued
  • Table 72 : Patents Applied

10: Company Profiles

  • Allergan Plc
  • Ardelyx Inc.
  • Astellas Pharma Inc.
  • Astrazeneca
  • Celgene Corp.
  • Clovis Oncology
  • Daewoong Pharmaceutical Co., Ltd.
  • ELI Lilly And Company
  • Glaxosmithkline
  • Horizon Pharma Plc
  • Immunogenx
  • Immunomedics
  • Merck & Co.
  • Merrimack Pharmaceuticals Inc.
  • New Link Genetics
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Roche
  • Sanofi
  • Shire
  • Sucampo Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • Synthetic Biologics
  • Taiho Pharmaceutical Co., Ltd.
  • Takeda Pharmaceuticals
  • Valeant Pharmaceuticals

List Of Tables

Summary Table : Global Market For Gastrointestinal Disorder Therapeutics And Diagnostics, By Category, Through 2021
Table 1 : U.S. Incidence Of Individual Pathogens
Table 2 : Estimated Incidence/Prevalence/Mortality Of Selected Gi Conditions In The U.S.
Table 3 : Gastric Cancer Prevalence, 2012-2021
Table 4 : Prevalence Estimates Of Ibd, By Country
Table 5 : U.S. Prevalence Of Inflammatory Bowel Disease
Table 6 : U.S. Incidence Of Inflammatory Bowel Disease
Table 7 : Global Prevalence Of Inflammatory Bowel Disease
Table 8 : Commonly Used Laxative Agents
Table 9 : Prevalence Of Gerd Symptoms
Table 10 : U.S. States That Provide Complete Range Of Colorectal Diagnostic Screening
Table 11 : Global Market For Prescription Gi Therapies, By Category, Through 2021
Table 12 : Key Anti-Diarrheal Brands
Table 13 : Global Market For Prescription Antidiarrheal Therapies, By Region, Through 2021
Table 14 : Antiemetics: Site Of Action And Examples
Table 15 : Marketed Antiemetic Products
Table 16 : Global Market For Prescription Antiemetic Therapies, By Region, Through 2021
Table 17 : Marketed Gastrointestinal Cancer Products
Table 18 : Global Prescription Gastrointestinal Cancer Therapies, By Region, Through 2021
Table 19 : Marketed H2 Inhibitor Products
Table 20 : Global Prescription H2 Inhibitor Market, By Region, Through 2021
Table 21 : Proton Pump Inhibitors: Therapy And Ph
Table 22 : Marketed Proton Pump Inhibitor Products
Table 23 : Global Prescription Proton Pump Inhibitor Market, By Region, Through 2021
Table 24 : Pharmacologic Management Of Chronic Constipation In The U.S.
Table 25 : Marketed Laxative Products
Table 26 : Pharmacologic Management Of Chronic Constipation
Table 27 : Global Prescription Laxative Market, By Region, Through 2021
Table 28 : Marketed Anti-Inflammatory Bowel Products
Table 29 : Global Market For Prescription Bowel Ant-Inflammatories, By Region, Through 2021
Table 30 : Global Market For Other Prescription Gastrointestinal Therapies, By Region, Through 2021
Table 31 : Key Brands Of Antacids In U.S. And Other Markets
Table 32 : Global Otc Antacid Market, By Region, Through 2021
Table 33 : Marketed Otc Antidiarrheal Products
Table 34 : Global Otc Antidiarrheal Market, By Region, Through 2021
Table 35 : Marketed Otc H2 Inhibitor Products
Table 36 : Global Market For Otc H2 Inhibitors, By Region, Through 2021
Table 37 : Marketed Otc Proton Pump Inhibitor Products
Table 38 : Global Market For Otc Proton Pump Inhibitors, By Region, Through 2021
Table 39 : Marketed Otc Laxative Products
Table 40 : Global Otc Laxative Market, By Region, Through 2021
Table 41 : Global Market For Otc Gastrointestinal Drugs, By Product Category, Through 2021
Table 42 : Enteric Disease Testing Methods
Table 43 : Enteric Disease Diagnostics, By Disease Type
Table 44 : Global Market For Diagnostics For Gi Diseases, By Type, Through 2021
Table 45 : Commercially Available Molecular Tests For Campylobacter And Salmonella
Table 46 : Global Market For Campylobacter Diagnostic Tests, By Region,Through 2021
Table 47 : Commercially Available Molecular Tests For Noroviruses
Table 48 : Global Market For Norovirus Diagnostic Tests, By Region, Through 2021
Table 49 : Commercially Available Molecular Tests For Rotavirus
Table 50 : Global Market For Rotavirus Diagnostic Tests, By Region, Through 2021
Table 51 : Commercially Available Molecular Tests For Giardia Parasite
Table 52 : Global Market For Giardia Parasite Diagnostic Tests, By Region, Through 2021
Table 53 : Commercially Available Molecular Tests For E. Coli
Table 54 : Global Market For E. Coli Diagnostic Tests, By Region, Through 2021
Table 55 : Commercially Available Molecular Tests For Cryptosporidium
Table 56 : Global Market For Cryptosporidium Diagnostic Tests, By Region, Through 2021
Table 57 : Commercially Available Molecular Tests For Shigella
Table 58 : Global Market For Shigella Diagnostic Tests, By Region, Through 2021
Table 59 : Commercially Available Molecular Tests For Salmonella
Table 60 : Global Market For Typhoid Diagnostic Tests, By Region, Through 2021
Table 61 : Commercially Available Molecular Tests For Amebiasis
Table 62 : Global Market For Amebiasis Diagnostic Tests, By Region, Through 2021
Table 63 : Commercially Available Molecular Tests For Cholera
Table 64 : Global Market For Cholera Diagnostic Tests, By Region, Through 2021
Table 65 : Commercially Available Molecular Tests For H. Pylori
Table 66 : Global Market For Other (Salmonella, H. Pylori) Diagnostic Tests, By Region, Through 2021
Table 67 : Emerging Novel Diagnostic And Therapeutic Endoscopic Techniques
Table 68 : Global Market For Medical Devices (Endoscopy), By Region, Through 2021
Table 69 : Global Market For Gastro-Diagnostics, Through 2021
Table 70 : Developmental Pipeline Of GI Therapies
Table 71 : Patents Issued
Table 72 : Patents Applied

List Of Figures

Summary Figure : Global Market For Gastrointestinal Disorder Therapeutics And Diagnostics, By Category, 2015-2021
Figure 1 : Global Market For Prescription Antidiarrheal Therapies, By Region, 2015-2021
Figure 2 : Global Market For Prescription Antiemetic Therapies, By Region, 2015-2021
Figure 3 : Global Prescription Gastrointestinal Cancer Therapies, By Region, 2015-2021
Figure 4 : Global Prescription H2 Inhibitor Market, By Region, 2015-2021
Figure 5 : Global Prescription Proton Pump Inhibitor Market, By Region, 2015-2021
Figure 6 : Global Prescription Laxative Market, By Region, 2015-2021
Figure 7 : Global Market For Prescription Bowel Anti-Inflammatories, By Region, 2015-2021
Figure 8 : Global Market For Other Prescription Gastrointestinal Therapies, By Region, 2015-2021
Figure 9 : Global Otc Antacid Market, By Region, 2015-2021
Figure 10 : Global Otc Antidiarrheal Market, By Region, 2015-2021
Figure 11 : Global Market For OTC H2 Inhibitors, By Region, 2015-2021
Figure 12 : Global Market For OTC Proton Pump Inhibitors, By Region, 2015-2021
Figure 13 : Global Otc Laxative Market, By Region, 2015-2021
Figure 14 : Global Market For OTC Gastrointestinal Drugs, By Product Category, 2015-2021
Figure 15 : Global Market For Diagnostics For Gi Diseases, By Type, 2015-2021
Figure 16 : Global Market For Campylobacter Diagnostic Tests, By Region, 2015-2021
Figure 17 : Global Market For Norovirus Diagnostic Tests, By Region, 2015-2021
Figure 18 : Global Market For Rotavirus Diagnostic Tests, By Region, 2015-2021
Figure 19 : Global Market For Giardia Parasite Diagnostic Tests, By Region, 2015-2021
Figure 20 : Global Market For E. Coli Diagnostic Tests, By Region, 2015-2021
Figure 21 : Global Market For Cryptosporidium Diagnostic Tests, By Region, 2015-2021
Figure 22 : Global Market For Shigella Diagnostic Tests, By Region, 2015-2021
Figure 23 : Global Market For Typhoid Diagnostic Tests, By Region, 2015-2021
Figure 24 : Global Market For Amebiasis Diagnostic Tests, By Region, 2015-2021
Figure 25 : Global Market For Cholera Diagnostic Tests, By Region, 2015-2021
Figure 26 : Global Market For Other (Salmonella, H. Pylori) Diagnostic Tests, By Region, 2015-2021
Figure 27 : Global Market For Medical Devices (Endoscopy), By Region, 2015-2021
Figure 28 : Global Market For Gastro-Diagnostics, 2015-2021

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Allergan Plc
  • Astrazeneca
  • ELI Lilly And Company
  • Immunogenx
  • New Link Genetics
  • Roche
  • MORE

Analyst’s Credentials

Yogita Zutshi has 15 years of industry experience working in the areas of clinical operations, medical/regulatory writing and market research experience in the pharmaceutical domain. She has an MS in Clinical Research, an MS in Organic Chemistry, and a Bachelor’s degree in Education. She has also worked on research projects in Clinical Data Management (CDM), and has developed training modules for the clinical and pharmacovigilance areas. She has a high level of proficiency in customized market topline studies, secondary market research and competitive intelligence.

Note: Product cover images may vary from those shown
5 of 6
  • Allergan Plc
  • Ardelyx Inc.
  • Astellas Pharma Inc.
  • Astrazeneca
  • Celgene Corp.
  • Clovis Oncology
  • Daewoong Pharmaceutical Co., Ltd.
  • ELI Lilly And Company
  • Glaxosmithkline
  • Horizon Pharma Plc
  • Immunogenx
  • Immunomedics
  • Merck & Co.
  • Merrimack Pharmaceuticals Inc.
  • New Link Genetics
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Roche
  • Sanofi
  • Shire
  • Sucampo Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • Synthetic Biologics
  • Taiho Pharmaceutical Co., Ltd.
  • Takeda Pharmaceuticals
  • Valeant Pharmaceuticals
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll